Landos Biopharma (NASDAQ:LABP) reported its Q4 earnings results on Thursday, March 21, 2024 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Landos Biopharma missed estimated earnings by -9.0%, reporting an EPS of $-0.99 versus an estimate of $-0.91.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.06 which was followed by a 7.000000000000001% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Landos Biopharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.